Health Care & Life Sciences » Pharmaceuticals | Mezzion Pharma Co. Ltd.

Mezzion Pharma Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
518,273.00
3,330,969.00
5,161,177.00
12,984,661.00
14,881,752.00
Depreciation, Depletion & Amortization
48,098.00
150,937.00
343,353.00
414,903.00
62,369.00
Other Funds
-
9,395,039.60
9,400,039.60
-
-
Funds from Operations
302,707.20
1,783,462.60
635,663.80
6,494,116.00
16,254,136.10
Changes in Working Capital
3,248,884.00
2,718,908.00
2,407,885.00
416,961.00
3,040,298.00
Net Operating Cash Flow
3,551,591.20
4,502,370.60
1,772,221.20
6,077,155.00
13,213,838.10
Capital Expenditures
6,626.90
251,427.70
564,103.20
169,022.60
2,048,454.10
Sale of Fixed Assets & Businesses
300.00
-
5,320.20
633,401.00
100.00
Purchase/Sale of Investments
13,624,140.80
1,602,337.00
528,493.30
37,955,551.50
38,492,200.10
Net Investing Cash Flow
13,617,813.90
2,479,585.60
977,877.80
36,812,182.00
36,422,046.70
Cash Dividends Paid - Total
182,234.40
-
-
-
-
Issuance/Reduction of Debt, Net
-
-
42,000,000.00
1,800,000.00
23,700,000.00
Net Financing Cash Flow
182,234.40
16,297,944.70
24,946,767.80
1,800,000.00
11,250,160.00
Net Change in Cash
9,687,367.60
9,436,125.30
26,104,915.00
44,739,356.30
11,473,395.80
Free Cash Flow
3,558,218.10
4,753,798.30
1,208,118.00
6,246,177.60
13,933,692.20
Other Sources
-
3,050,000.00
124,488.60
750,000.00
-
Change in Capital Stock
-
6,902,905.10
7,653,192.60
-
12,449,840.00
Exchange Rate Effect
196,620.70
120,136.80
363,803.70
50,019.40
484,652.80
Other Uses
-
3,675,820.90
15,090.00
71,008.80
21,799.30

About Mezzion Pharma Co.

View Profile
Address
3th Floor, C&H Building
Seoul SL 06167
Korea, Republic Of
Employees -
Website http://www.mezzion.co.kr
Updated 09/14/2018
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea.